331 related articles for article (PubMed ID: 17161050)
1. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ
Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
[TBL] [Abstract][Full Text] [Related]
2. Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial.
Esposito K; Maiorino MI; Di Palo C; Gicchino M; Petrizzo M; Bellastella G; Saccomanno F; Giugliano D
Diabetes Obes Metab; 2011 May; 13(5):439-45. PubMed ID: 21255215
[TBL] [Abstract][Full Text] [Related]
3. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
Rudofsky G; Reismann P; Grafe IA; Konrade I; Djuric Z; Tafel J; Buchbinder S; Zorn M; Humpert PM; Hamann A; Morcos M; Nawroth PP; Bierhaus A
Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation.
George J; Goldstein E; Abashidze S; Deutsch V; Shmilovich H; Finkelstein A; Herz I; Miller H; Keren G
Eur Heart J; 2004 Jun; 25(12):1003-8. PubMed ID: 15191769
[TBL] [Abstract][Full Text] [Related]
5. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U
Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079
[TBL] [Abstract][Full Text] [Related]
6. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.
Werner C; Kamani CH; Gensch C; Böhm M; Laufs U
Diabetes; 2007 Oct; 56(10):2609-15. PubMed ID: 17623816
[TBL] [Abstract][Full Text] [Related]
7. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
Umpierrez G; Issa M; Vlajnic A
Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
[TBL] [Abstract][Full Text] [Related]
8. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia.
Zhu J; Wang X; Chen J; Sun J; Zhang F
Arch Med Res; 2006 May; 37(4):484-9. PubMed ID: 16624647
[TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
Watts GF; Playford DA; Croft KD; Ward NC; Mori TA; Burke V
Diabetologia; 2002 Mar; 45(3):420-6. PubMed ID: 11914748
[TBL] [Abstract][Full Text] [Related]
10. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma.
Fadini GP; Pagano C; Baesso I; Kotsafti O; Doro D; de Kreutzenberg SV; Avogaro A; Agostini C; Dorigo MT
Acta Ophthalmol; 2010 Feb; 88(1):135-41. PubMed ID: 19549102
[TBL] [Abstract][Full Text] [Related]
11. Daily intake of thiamine correlates with the circulating level of endothelial progenitor cells and the endothelial function in patients with type II diabetes.
Wong CY; Qiuwaxi J; Chen H; Li SW; Chan HT; Tam S; Shu XO; Lau CP; Kwong YL; Tse HF
Mol Nutr Food Res; 2008 Dec; 52(12):1421-7. PubMed ID: 18925614
[TBL] [Abstract][Full Text] [Related]
12. Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head.
Feng Y; Yang SH; Xiao BJ; Xu WH; Ye SN; Xia T; Zheng D; Liu XZ; Liao YF
Bone; 2010 Jan; 46(1):32-40. PubMed ID: 19747991
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients.
Makino H; Okada S; Nagumo A; Sugisawa T; Miyamoto Y; Kishimoto I; Akie TK; Soma T; Taguchi A; Yoshimasa Y
Diabetes Res Clin Pract; 2008 Sep; 81(3):327-30. PubMed ID: 18639363
[TBL] [Abstract][Full Text] [Related]
14. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.
Takebayashi K; Suetsugu M; Wakabayashi S; Aso Y; Inukai T
Metabolism; 2007 Apr; 56(4):451-8. PubMed ID: 17378999
[TBL] [Abstract][Full Text] [Related]
15. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
16. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia.
Chen JZ; Zhang FR; Tao QM; Wang XX; Zhu JH; Zhu JH
Clin Sci (Lond); 2004 Sep; 107(3):273-80. PubMed ID: 15099190
[TBL] [Abstract][Full Text] [Related]
17. Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2.
Forst T; Lübben G; Hohberg C; Kann P; Sachara C; Gottschall V; Friedrich C; Rosskopf R; Pfützner A
Microcirculation; 2005; 12(7):543-50. PubMed ID: 16207627
[TBL] [Abstract][Full Text] [Related]
18. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
[TBL] [Abstract][Full Text] [Related]
19. Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.
Chen LL; Yu F; Zeng TS; Liao YF; Li YM; Ding HC
Eur J Pharmacol; 2011 Jun; 659(2-3):296-301. PubMed ID: 21453695
[TBL] [Abstract][Full Text] [Related]
20. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
